We conducted a voluntary survey of laboratories and manufacturers to assess the current quality of analytical assays for serum digoxin. 
, in terms of imprecision (3) , or in terms of differences between duplicate samples analyzed over a time span of three to six months (4) . One study was conducted by analyzing three control sera by 16 different kits in one laboratory (5) , while in another study calibrators for a standard curve were distributed along with control and abnormal sera (6) . In our study, we used survey specimens that had been prepared from digoxin of established purity, that had a demonstrated stability, and that had been of digoxin present. Another goal of our experiment was to include laboratories of manufacturers of digoxin test kits as well as clinical laboratories. not included in this summary report may be found in the complete report (7) , and may be obtained upon request from the authors. from the mean values for the same specimen determined by the remaining laboratories. The therapeutic range for digoxin in serum has been reported to be quite narrow, and the toxic effects of the drug manifest themselves at only slightly higher serum levels (10, 11) Because we assign no definitive values for the digoxin concentration in the survey specimens and because the survey data are an uncontrolled sample, we are not able to judge either the iodinated or the tritiated participant values as being closer to the "true" digoxin concentration. Figure 3 is In the great majority of sets, 278 (83.5%), laboratories reported using a zero concentration digoxin standard as the low calibrator.
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In the remaining sets, 44 (13.2%) re- (36.0%) using 2.00 ftg/L, 32 (9.6%) using 2.10 zg/L, and 43 (12.9%) using 2.40 ig/L.
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